A Study of Suvorexant for Insomnia in People with Opioid Use Disorder
Phase 3
300
about 1.7 years
18–70
10 sites in CT, GA, MD +6
What this study is about
This trial is testing if suvorexant, a medication, helps people with opioid use disorder (OUD) sleep better. Researchers are also looking at how safe and well-tolerated suvorexant is compared to a placebo.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Placebo
- 2.Take Suvorexant
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
You may get a placebo/standard care, and you won't know which.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
suvorexant
oral (Oral Tablet)
Primary: Change from Baseline in Total Sleep Time at Week 8, Number of Participants Who Discontinue Study Treatment Due to an AE, Number of Participants Who Experience One or More Adverse Events (AEs), Number of Participants Who Experience One or More Serious Adverse Events (SAEs)
Secondary: Change from Baseline in Wakefulness after Persistent Sleep Onset at Week 8